Chemfab Alkalis board meeting on May 13, 2026 to approve audited standalone and consolidated financial results for Q4 and FY ended March 31, 2026.
Board to consider declaration of dividend subject to shareholder approval.
Trading window closed from April 1, 2026 until May 15, 2026 for insiders due to results announcement.